Michael S. Vincent

4.0k citations

75 papers · 2.9k indexed · 1 hit paper · h-index 30

Impact in

Immunology top 2%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
- Psoriasis: Treatment and Pathogenesis
Dermatology top 1%
- Dermatology and Skin Diseases

Papers in

Dermatology 14
- Dermatology and Skin Diseases 10
Immunology and Allergy 8
- Allergic Rhinitis and Sensitization 7

Co-authors: Michael B. Brenner Elena Peeva Jenny E. Gumperz Christopher Banfield David S. Leslie Jean S. Beebe Linda Zhu Xiaowei Xiong
Journals: Journal of Crohn s and Colitis (6 papers)Journal of Investigative Dermatology (4 papers)Arthritis & Rheumatology (4 papers)Journal of the American Academy of Dermatology (4 papers)Annals of the Rheumatic Diseases (4 papers)
Partner nations: United States Australia Poland

In The Last Decade

Michael S. Vincent

74 papers receiving 2.9k citations

Hit Papers

align trajectories log scale

A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results 2021 · 138 citations

Peers

Countries citing papers authored by Michael S. Vincent

Since Specialization

Citations

This map shows the geographic impact of Michael S. Vincent's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. Vincent with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. Vincent more than expected).

Fields of papers citing papers by Michael S. Vincent

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. Vincent. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. Vincent. The network helps show where Michael S. Vincent may publish in the future.

Co-authors

The 25 scholars most cited alongside Michael S. Vincent, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael S. Vincent Line = papers co-authored together Michael S. Vincent links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Efficacy and Safety of Zimlovisertib, Ritlecitinib, and Tofacitinib, Alone and in Combination, in Patients With Moderate to Severe Rheumatoid Arthritis and an Inadequate Response to Methotrexate Arthritis & Rheumatology ·Spencer I. Danto, M.P. Salganik, Anindita Banerjee, Paweł Hrycaj, R. L. Smelyansky, Graydon Hough, Ravi Shankar Prasad Singh, Steven A. Gilbert, Karen Page, Elena Peeva, Michael S. Vincent, Jean S. Beebe	2025	2
2	OP09 Oral ritlecitinib and brepocitinib in patients with moderate to severe active Crohn’s Disease: Data from the PIZZICATO umbrella study Journal of Crohn s and Colitis ·Séverine Vermeire, Jessica R. Allegretti, T. G. Appleton, Millie D. Long, Jarosław Leszczyszyn, S Schreiber, (unknown), Jarosław Kierkuś, V. V. Tbileli, Michael S. Vincent, Graydon Hough, Hongbo Yuan, Anindita Banerjee, Jeremy D. Gale, Kenneth E. Hung	2024	3
3	Exploratory pharmacodynamics and efficacy of PF-06817024 in a Phase 1 study of patients with chronic rhinosinusitis and atopic dermatitis Allergy Asthma and Clinical Immunology ·Spencer I. Danto, Nikolaos Tsamandouras, Padma Reddy, Steven A. Gilbert, Jessica Mancuso, Karen Page, Jean S. Beebe, Elena Peeva, Michael S. Vincent	2024	1
4	A Phase 1, randomized, double-blind, placebo-controlled, single- and multiple-dose escalation study to evaluate the safety and pharmacokinetics/pharmacodynamics of PF-06835375, a C-X-C chemokine receptor type 5 directed antibody, in patients with systemic lupus erythematosus or rheumatoid arthritis Arthritis Research & Therapy ·Stanley M. Cohen, Jean S. Beebe, Vishala Chindalore, 喜一飯田, Mina Hassan‐Zahraee, Madhurima Saxena, AB Lux, Craig Hyde, Marta Karaźniewicz-Łada, Robert D. Levin, Shannon L. Lubaczewski, M.P. Salganik, Editors Marrane et marronne, Erin Stevens, Elena Peeva, Michael S. Vincent, Roland Martinꝉ, Myron Chu	2024	5
5	Efficacy and Safety of PF-07038124 in Patients With Atopic Dermatitis and Plaque Psoriasis JAMA Dermatology ·Lawrence F. Eichenfield, Sanela Tarabar, Seth Forman, 正志倉前, Gang Feng, Gerald J. Fetterly, J.M. Linfort, Elena Peeva, Michael S. Vincent, بوبكر مصطفی	2023	11
6	Efficacy and Safety of the TYK2/JAK1 Inhibitor Brepocitinib for Active Psoriatic Arthritis: A Phase IIb Randomized Controlled Trial Arthritis & Rheumatology ·Philip J. Mease, Philip Helliwell, И Г Минервин, Pamela Lyle, Andrew J.K. Östör, Elena Peeva, Michael S. Vincent, Amos C. Miller, Vanja Sikirica, Randall Winnette, Ruolun Qiu, Gang Li, Gang Feng, Jean S. Beebe, Roland Martinꝉ	2023	36
7	Safety and Efficacy of Ritlecitinib and Brepocitinib in Alopecia Areata: Results from the Crossover Open-Label Extension of the ALLEGRO Phase 2a Trial SHILAP Revista de lepidopterología ·Brett King, Emma Guttman‐Yassky, Elena Peeva, Anindita Banerjee, Linda Zhu, Justin Cho, Lori Ann Cox, Michael S. Vincent, Rodney Sinclair	2022	15
8	Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers Journal of Allergy and Clinical Immunology ·Emma Guttman‐Yassky, Ana B. Pavel, Aisleen Diaz, Ning Zhang, Ester Del Duca, Yeriel Estrada, Brett King, Anindita Banerjee, Christopher Banfield, Lori Ann Cox, Martin E. Dowty, Karen Page, Michael S. Vincent, Weidong Zhang, Linda Zhu, Elena Peeva	2021	74
9	Patient-Reported Symptoms and Disease Impacts in Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Phase 2b Study With Abrocitinib Dermatitis ·Eric L. Simpson, Andreas Wollenberg, Robert Bissonnette, Jonathan I. Silverberg, Jocelyne Papacharalambous, Linda Zhu, Weidong Zhang, Jean S. Beebe, Michael S. Vincent, Elena Peeva, Andrew G. Bushmakin, Joseph C. Cappelleri, Linda Chen, Vanja Sikirica, Jason Xenakis	2021	18
10	Reviving an R&D pipeline: a step change in the Phase II success rate Drug Discovery Today ·Sper Sper C Uriati, M. KUECUEK, Charlotte Allerton, Kathrin U. Jansen, Michael S. Vincent, Mikael Dolsten	2020	24
11	Discovering in vivo cytokine-eQTL interactions from a lupus clinical trial Genome biology ·Emma E. Davenport, Tiffany Amariuta, María Gutiérrez‐Arcelus, Kamil Slowikowski, Harm-Jan Westra, Yang Luo, Ciyue Shen, Deepak A. Rao, Ying Zhang, Stephen Pearson, David von Schack, Jean S. Beebe, Nan Bing, Sally John, Michael S. Vincent, Baohong Zhang, Soumya Raychaudhuri	2018	27
12	517 Effects of the oral janus kinase 1 (JAK1) inhibitor PF-04965842 on patient-reported outcomes (PROs) in adults with moderate to severe atopic dermatitis (AD) Journal of Investigative Dermatology ·Eric L. Simpson, Andreas Wollenberg, Robert Bissonnette, Jonathan I. Silverberg, Jocelyne Papacharalambous, Linda Zhu, José F. Gil de Muro, Jean S. Beebe, Michael S. Vincent, Elena Peeva, Andrew G. Bushmakin, Joseph C. Cappelleri, Amanda Ishak Prag	2018	1
13	Deep Brain Stimulation associated gliosis: A post-mortem study Parkinsonism & Related Disorders ·Vinata Vedam‐Mai, A Emaeili, Akiyo NOZUMA, Michael S. Vincent, Braden D. Rosenberg, Ahmad Elkouzi, Anthony T. Yachnis, Kelly D. Foote, Michael S. Okun	2018	22
14	The Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a TYK2/JAK1 Inhibitor (PF‐06700841) in Healthy Subjects and Patients With Plaque Psoriasis The Journal of Clinical Pharmacology ·Christopher Banfield, Matthew Scaramozza, Weidong Zhang, Elizabeth Kieras, Karen Page, Andrew Fensome, Michael S. Vincent, Martin E. Dowty, Kosalaram Goteti, Peter Winkle, Elena Peeva	2017	71
15	Markers of Inflammation in Alveolar Cells Exposed to Fine Particulate Matter From Prescribed Fires and Urban Air Journal of Occupational and Environmental Medicine ·Theodore A. Myatt, Michael S. Vincent, Lester Kobzik, Luke P. Naeher, David L. MacIntosh, Helen Suh	2011	18
16	CD1a-, b-, and c-Restricted TCRs Recognize Both Self and Foreign Antigens The Journal of Immunology ·Michael S. Vincent, Xiaowei Xiong, Ethan Grant, Wei Peng, Michael B. Brenner	2005	42
17	Understanding the function of CD1-restricted T cells Nature Immunology ·Michael S. Vincent, Jenny E. Gumperz, Michael B. Brenner	2003	105
18	CD1-mediated γ/δ T Cell Maturation of Dendritic Cells The Journal of Experimental Medicine ·David S. Leslie, Michael S. Vincent, Franca Spada, Hiranmoy Das, Masahiko Sugita, Craig T. Morita, Michael B. Brenner	2002	169
19	Molecular Recognition of Human CD1b Antigen Complexes: Evidence for a Common Pattern of Interaction with αβ TCRs The Journal of Immunology ·Loren W. Shaffer, Gerald F. Watts, Abdijapar Shamshiev, Gennaro De Libero, Anne E. Clatworthy, Michael S. Vincent, Michael B. Brenner, Samuel M. Behar, Kayvan Niazi, Robert L. Modlin, Steven C. Almo, David A. Ostrov, Stanley G. Nathenson, Steven A. Porcelli	2000	45
20	Purification of a [3H]Dihydrotetrabenazine-Binding Protein from Bovine Adrenal Medulla Molecular Pharmacology ·Michael S. Vincent, Joseph A. Near	1991	15

About Michael S. Vincent

Michael S. Vincent is a scholar working on Dermatology, Immunology and Allergy, Rheumatology, Immunology and Virology, having authored 75 papers that have together received 2.9k indexed citations. Recurring topics across this work include Inflammatory Bowel Disease (12 papers), T-cell and B-cell Immunology (11 papers), Dermatology and Skin Diseases (10 papers), Asthma and respiratory diseases (9 papers), Immune Cell Function and Interaction (8 papers), Allergic Rhinitis and Sensitization (7 papers), Microscopic Colitis (7 papers) and Cytokine Signaling Pathways and Interactions (7 papers). The work is most often cited by research in Immunology (1.3k citations), Dermatology (487 citations), Urology (326 citations), Rheumatology (661 citations) and Immunology and Allergy (201 citations). Michael S. Vincent has collaborated with scholars based in United States, Australia and Poland. Frequent co-authors include Michael B. Brenner, Elena Peeva, Jenny E. Gumperz, Christopher Banfield, David S. Leslie, Jean S. Beebe, Linda Zhu, Xiaowei Xiong, Ethan Grant and Anindita Banerjee. Their work appears in journals such as Journal of Crohn s and Colitis, Journal of Investigative Dermatology, Arthritis & Rheumatology, Journal of the American Academy of Dermatology and Annals of the Rheumatic Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact